BANK VONTOBEL/PUT/MERCK & CO./130/0.1/21.06.24 Share Price

Warrant

DE000VM9PRL8

Market Closed - Deutsche Boerse AG 11:20:33 10/05/2024 pm IST
0.235 EUR -6.00% Intraday chart for BANK VONTOBEL/PUT/MERCK & CO./130/0.1/21.06.24
Current month-24.19%
1 month-60.83%
Date Price Change Volume
10/24/10 0.235 -6.00% 0
09/24/09 0.25 -10.71% 0
08/24/08 0.28 -12.50% 0
07/24/07 0.32 -21.95% 0
06/24/06 0.41 +2.50% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 11:20 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM9PRL
ISINDE000VM9PRL8
Date issued 02/02/2024
Strike 130 $
Maturity 21/06/2024 (41 Days)
Parity 10 : 1
Emission price 0.67
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.04
Lowest since issue 0.232
Spread 0.01
Spread %4.00%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW